Denitrification in a simple wastewater treatment system

In this research, three anaerobic filters were operated with a 9 hour hydraulic detention time, and its effluent was disposed on four sand filters' bed in different application rates. On the first sand filter, 50 L.m-2 were disposed once a day. On the second, the third and the fourth filters, the same load was disposed in twice, three and four times a day, distributed between 9 am and 4 pm, corresponding to rates of 100, 150 and 200 L.m-2.d-1. After the sand filter, the effluent was conducted to the denitrification reactors filled up with grit. As result, the sand filters have shown a great nitrification capacity and, after the external carbon adding, the denitrification reactor, where 50 L.m-2 was disposed a day, showed a decrease of 43.5% in N-total concentrationNesta pesquisa, foram operados três filtros anaeróbios com tempo de detenção hidráulica nominal de nove horas, sendo o efluente gerado disposto nos leitos de quatro filtros de areia em distintas taxas de aplicações. No primeiro filtro de areia, foram aplicados 50 L.m-2 uma vez por dia. No segundo, terceiro e quarto filtros, essa mesma carga foi disposta em 2, 3 e 4 horários, com aplicações espaçadas entre as 9h e as 16h, correspondendo às taxas de 100, 150 e 200 L.m-2.dia-1. Após a passagem pelo leito de areia, o efluente era encaminhado para reatores de desnitrificação preenchidos com brita 1. Os filtros de areia apresentaram uma grande capacidade de nitrificação e, após a adição da fonte externa de carbono, o reator de desnitrificação que recebia uma única disposição diária de 50 L.m-2 propiciou uma diminuição na concentração de N-total de 43,5%.38139

Wastewater treatment and reuse water production using sand filters

In this research it was studied a system composed by the anaerobic filter combined with a sand filter for the wastewater treatment. For this, three anaerobic filters were operated with hydraulic detention time of nine hours which had the effluent disposed over four sand filters in different frequencies of application. On the first sand filter, 50 L.m(-2) were applied once a day. On the second, the third and the fourth filters, the same load was disposed in twice, three and four times a day, distributed between 9 a. m. and 4 p. m. The system presented a final effluent suitable for the COD and BOD legislation maximum limit to be discharged into water body (Decreto Paulista no 8,468/1976), showing the viability of dispose a higher quantity of effluent then the one suggested by NBR 13969/1997, which guides the constructive aspects for this kind of treatment.17328729

Wastewater treatment and reuse water production using sand filters

Nesta pesquisa estudou-se um sistema composto pela combinação de filtro anaeróbio com filtro de areia para o tratamento de esgoto. Para isso, foram avaliados três filtros anaeróbios operados com tempo de detenção hidráulica de nove horas, que tinham o efluente disposto sobre quatro filtros de areia em distintas taxas de aplicações. No primeiro filtro de areia aplicaram-se 50 L.m-2 uma vez por dia. No segundo, terceiro e quarto filtros, essa mesma carga foi disposta em dois, três e quatro horários, espaçadas entre às 9:00 e às 16:00 horas. O sistema apresentou um efluente final com qualidade que atendia os padrões para reúso e demanda bioquímica de oxigênio abaixo do limite para o lançamento em corpos hídricos (Decreto de Paulista nº 8.468/1976), indicando a viabilidade de disposição de taxas superiores às sugeridas pela NBR 13969/1997, a qual orienta os aspectos construtivos para esta forma de tratamento173287294In this research it was studied a system composed by the anaerobic filter combined with a sand filter for the wastewater treatment. For this, three anaerobic filters were operated with hydraulic detention time of nine hours which had the effluent disposed over four sand filters in different frequencies of application. On the first sand filter, 50 L.m-2 were applied once a day. On the second, the third and the fourth filters, the same load was disposed in twice, three and four times a day, distributed between 9 a.m. and 4 p.m. The system presented a final effluent suitable for the COD and BOD legislation maximum limit to be discharged into water body (Decreto Paulista nº 8,468/1976), showing the viability of dispose a higher quantity of effluent then the one suggested by NBR 13969/1997, which guides the constructive aspects for this kind of treatmen

Tratamento de esgoto e produção de água de reúso com o emprego de filtros de areia

In this research it was studied a system composed by the anaerobic filter combined with a sand filter for the wastewater treatment. For this, three anaerobic filters were operated with hydraulic detention time of nine hours which had the effluent disposed over four sand filters in different frequencies of application. on the first sand filter, 50 L.m(-2) were applied once a day. on the second, the third and the fourth filters, the same load was disposed in twice, three and four times a day, distributed between 9 a. m. and 4 p. m. The system presented a final effluent suitable for the COD and BOD legislation maximum limit to be discharged into water body (Decreto Paulista no 8,468/1976), showing the viability of dispose a higher quantity of effluent then the one suggested by NBR 13969/1997, which guides the constructive aspects for this kind of treatment

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial

Background: Patients with stable coronary artery disease and diabetes with previous percutaneous coronary intervention (PCI), particularly those with previous stenting, are at high risk of ischaemic events. These patients are generally treated with aspirin. In this trial, we aimed to investigate if these patients would benefit from treatment with aspirin plus ticagrelor. Methods: The Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) was a phase 3 randomised, double-blinded, placebo-controlled trial, done in 1315 sites in 42 countries. Patients were eligible if 50 years or older, with type 2 diabetes, receiving anti-hyperglycaemic drugs for at least 6 months, with stable coronary artery disease, and one of three other mutually non-exclusive criteria: a history of previous PCI or of coronary artery bypass grafting, or documentation of angiographic stenosis of 50% or more in at least one coronary artery. Eligible patients were randomly assigned (1:1) to either ticagrelor or placebo, by use of an interactive voice-response or web-response system. The THEMIS-PCI trial comprised a prespecified subgroup of patients with previous PCI. The primary efficacy outcome was a composite of cardiovascular death, myocardial infarction, or stroke (measured in the intention-to-treat population). Findings: Between Feb 17, 2014, and May 24, 2016, 11 154 patients (58% of the overall THEMIS trial) with a history of previous PCI were enrolled in the THEMIS-PCI trial. Median follow-up was 3·3 years (IQR 2·8–3·8). In the previous PCI group, fewer patients receiving ticagrelor had a primary efficacy outcome event than in the placebo group (404 [7·3%] of 5558 vs 480 [8·6%] of 5596; HR 0·85 [95% CI 0·74–0·97], p=0·013). The same effect was not observed in patients without PCI (p=0·76, p interaction=0·16). The proportion of patients with cardiovascular death was similar in both treatment groups (174 [3·1%] with ticagrelor vs 183 (3·3%) with placebo; HR 0·96 [95% CI 0·78–1·18], p=0·68), as well as all-cause death (282 [5·1%] vs 323 [5·8%]; 0·88 [0·75–1·03], p=0·11). TIMI major bleeding occurred in 111 (2·0%) of 5536 patients receiving ticagrelor and 62 (1·1%) of 5564 patients receiving placebo (HR 2·03 [95% CI 1·48–2·76], p<0·0001), and fatal bleeding in 6 (0·1%) of 5536 patients with ticagrelor and 6 (0·1%) of 5564 with placebo (1·13 [0·36–3·50], p=0·83). Intracranial haemorrhage occurred in 33 (0·6%) and 31 (0·6%) patients (1·21 [0·74–1·97], p=0·45). Ticagrelor improved net clinical benefit: 519/5558 (9·3%) versus 617/5596 (11·0%), HR=0·85, 95% CI 0·75–0·95, p=0·005, in contrast to patients without PCI where it did not, p interaction=0·012. Benefit was present irrespective of time from most recent PCI. Interpretation: In patients with diabetes, stable coronary artery disease, and previous PCI, ticagrelor added to aspirin reduced cardiovascular death, myocardial infarction, and stroke, although with increased major bleeding. In that large, easily identified population, ticagrelor provided a favourable net clinical benefit (more than in patients without history of PCI). This effect shows that long-term therapy with ticagrelor in addition to aspirin should be considered in patients with diabetes and a history of PCI who have tolerated antiplatelet therapy, have high ischaemic risk, and low bleeding risk